Chevy Chase Trust’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $239K | Hold |
51,243
| – | – | ﹤0.01% | 620 |
|
|
2025
Q1 | $281K | Hold |
51,243
| – | – | ﹤0.01% | 614 |
|
|
2024
Q4 | $174K | Hold |
51,243
| – | – | ﹤0.01% | 629 |
|
|
2024
Q3 | $146K | Hold |
51,243
| – | – | ﹤0.01% | 623 |
|
|
2024
Q2 | $115K | Hold |
51,243
| – | – | ﹤0.01% | 607 |
|
|
2024
Q1 | $113K | Hold |
51,243
| – | – | ﹤0.01% | 608 |
|
|
2023
Q4 | $120K | Hold |
51,243
| – | – | ﹤0.01% | 618 |
|
|
2023
Q3 | $95.3K | Hold |
51,243
| – | – | ﹤0.01% | 615 |
|
|
2023
Q2 | $134K | Hold |
51,243
| – | – | ﹤0.01% | 617 |
|
|
2023
Q1 | $83.5K | Hold |
51,243
| – | – | ﹤0.01% | 632 |
|
|
2022
Q4 | $68.2K | Hold |
51,243
| – | – | ﹤0.01% | 644 |
|
|
2022
Q3 | $80K | Hold |
51,243
| – | – | ﹤0.01% | 627 |
|
|
2022
Q2 | $79K | Hold |
51,243
| – | – | ﹤0.01% | 629 |
|
|
2022
Q1 | $131K | Hold |
51,243
| – | – | ﹤0.01% | 640 |
|
|
2021
Q4 | $150K | Hold |
51,243
| – | – | ﹤0.01% | 664 |
|
|
2021
Q3 | $126K | Hold |
51,243
| – | – | ﹤0.01% | 657 |
|
|
2021
Q2 | $209K | Buy |
+51,243
| New | +$209K | ﹤0.01% | 662 |
|